Correlation Between Vyne Therapeutics and DiaMedica Therapeutics
Can any of the company-specific risk be diversified away by investing in both Vyne Therapeutics and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vyne Therapeutics and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vyne Therapeutics and DiaMedica Therapeutics, you can compare the effects of market volatilities on Vyne Therapeutics and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vyne Therapeutics with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vyne Therapeutics and DiaMedica Therapeutics.
Diversification Opportunities for Vyne Therapeutics and DiaMedica Therapeutics
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Vyne and DiaMedica is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Vyne Therapeutics and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Vyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vyne Therapeutics are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Vyne Therapeutics i.e., Vyne Therapeutics and DiaMedica Therapeutics go up and down completely randomly.
Pair Corralation between Vyne Therapeutics and DiaMedica Therapeutics
Given the investment horizon of 90 days Vyne Therapeutics is expected to under-perform the DiaMedica Therapeutics. In addition to that, Vyne Therapeutics is 1.18 times more volatile than DiaMedica Therapeutics. It trades about 0.0 of its total potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.06 per unit of volatility. If you would invest 297.00 in DiaMedica Therapeutics on September 4, 2024 and sell it today you would earn a total of 237.00 from holding DiaMedica Therapeutics or generate 79.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Vyne Therapeutics vs. DiaMedica Therapeutics
Performance |
| Timeline |
| Vyne Therapeutics |
| DiaMedica Therapeutics |
Vyne Therapeutics and DiaMedica Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Vyne Therapeutics and DiaMedica Therapeutics
The main advantage of trading using opposite Vyne Therapeutics and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vyne Therapeutics position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.| Vyne Therapeutics vs. Candel Therapeutics | Vyne Therapeutics vs. Cingulate Warrants | Vyne Therapeutics vs. Unicycive Therapeutics | Vyne Therapeutics vs. Cardio Diagnostics Holdings |
| DiaMedica Therapeutics vs. Milestone Pharmaceuticals | DiaMedica Therapeutics vs. Seres Therapeutics | DiaMedica Therapeutics vs. Inhibikase Therapeutics | DiaMedica Therapeutics vs. Oncolytics Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |